Handelsbanken Fonder Ab Relay Therapeutics, Inc. Transaction History
Handelsbanken Fonder Ab
- $23.2 Billion
- Q1 2024
A detailed history of Handelsbanken Fonder Ab transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 39,200 shares of RLAY stock, worth $249,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,200
Previous 29,500
32.88%
Holding current value
$249,312
Previous $325,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RLAY
# of Institutions
188Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$177 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$75.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$62.3 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$47.2 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$43.8 Million0.01% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $765M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...